SOURCE: IO Circuit

October 03, 2012 08:00 ET

Read This Before Trading the Following: TAGG, PROT, MIMV and ONCS

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO CIRCUIT.

NEW YORK, NY--(Marketwire - Oct 3, 2012) - AnotherWinningTrade.com is the #1 leader for breaking news & offers quality reports to investors looking for the most active traded companies in the small cap market.

TagLikeMe Corp. (OTCQB: TAGG) owns and operates TagLikeMe.com, an Internet services platform that combines the most commonly used functions of search and social media. The company saw trade volume surpassing 142 million shares yet the company closed down nearly 28%.

For a free report and detailed analysis on TAGG visit: http://www.anotherwinningtrade.com/ael/?sym=TAGG 

Proteonomix, Inc. (OTCQB: PROT) a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives saw shares down 56% for the trading session. Our exclusive report has the answers as to what caused this major decline.

For a free report and detailed analysis on PROT visit: http://www.anotherwinningtrade.com/ael/?sym=PROT

MIMVI, Inc. (OTCQB: MIMV) a search and recommendation technology company has seen shares soaring following news the company announced that it has finalized a partnership agreement with Microsoft Corp. See our exclusive report to find out what could happened next to the share price of MIMV.

For a free report and detailed analysis on MIMV visit: http://www.anotherwinningtrade.com/ael/?sym=MIMV

OncoSec Medical Inc. (OTCQB: ONCS) a biopharmaceutical company developing its advanced-stage ImmunoPulse, NeoPulse therapies to treat solid tumor cancers has seen share prices starting to advance higher. Find out what catalysts are behind this recent run up by reading our exclusive ONCS report.

For a free report and detailed analysis on ONCS visit: http://www.anotherwinningtrade.com/ael/?sym=ONCS

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information